WallStreetZenWallStreetZen

NASDAQ: TYRA
Tyra Biosciences Inc Stock

$13.18-0.12 (-0.9%)
Updated Feb 3, 2023
TYRA Price
$13.18
Fair Value Price
N/A
Market Cap
$556.16M
52 Week Low
$4.93
52 Week High
$14.61
P/E
18.83x
P/B
2.08x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$52.36M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.03
Operating Cash Flow
-$47M
Beta
1.43
Next Earnings
Mar 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A

TYRA Overview

Tyra Biosciences Incorporated is a preclinical-stage biopharmaceutical company developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting other cancers. Tyra Biosciences was incorporated in 2018 and is headquartered in Carlsbad, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TYRA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TYRA is poor value based on its earnings relative to its share price (18.83x), compared to the US market average (15.09x)
P/E vs Market Valuation
TYRA is poor value based on its earnings relative to its share price (18.83x), compared to the US Biotechnology industry average (10.7x)
P/E vs Industry Valuation
TYRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more TYRA due diligence checks available for Premium users.

Be the first to know about important TYRA news, forecast changes, insider trades & much more!

TYRA News

Valuation

TYRA fair value

Fair Value of TYRA stock based on Discounted Cash Flow (DCF)
Price
$13.18
Fair Value
$13.64
Undervalued by
3.35%

TYRA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
18.83x
Industry
10.7x
Market
15.09x
TYRA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TYRA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

TYRA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.08x
Industry
5.11x
TYRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TYRA's financial health

Profit margin

Revenue
$0.0
Net Income
-$12.5M
Profit Margin
0%
TYRA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$276.0M
Liabilities
$8.2M
Debt to equity
0.03
TYRA's short-term assets ($267.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TYRA's short-term assets ($267.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TYRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.2M
Investing
-$48.0k
Financing
$364.0k
TYRA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TYRA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TYRA$556.16M-0.90%18.83x2.08x
BLUE$551.35M+0.30%-1.10x3.47x
NSTG$563.49M-3.90%-3.85x6.79x
IMTX$547.39M-2.80%14.73x4.79x
CGEM$538.74M-1.18%5.05x0.92x

Tyra Biosciences Stock FAQ

What is Tyra Biosciences's quote symbol?

NASDAQ: TYRA) Tyra Biosciences trades on the NASDAQ under the ticker symbol TYRA. Tyra Biosciences stock quotes can also be displayed as NASDAQ: TYRA.

If you're new to stock investing, here's how to buy Tyra Biosciences stock.

What is the 52 week high and low for Tyra Biosciences (NASDAQ: TYRA)?

(NASDAQ: TYRA) Tyra Biosciences's 52-week high was $14.61, and its 52-week low was $4.93. It is currently -9.8% from its 52-week high and 167.34% from its 52-week low.

How much is Tyra Biosciences stock worth today?

(NASDAQ: TYRA) Tyra Biosciences currently has 42,197,431 outstanding shares. With Tyra Biosciences stock trading at $13.18 per share, the total value of Tyra Biosciences stock (market capitalization) is $556.16M.

Tyra Biosciences stock was originally listed at a price of $26.00 in Sep 15, 2021. If you had invested in Tyra Biosciences stock at $26.00, your return over the last 1 years would have been -49.31%, for an annualized return of -49.31% (not including any dividends or dividend reinvestments).

How much is Tyra Biosciences's stock price per share?

(NASDAQ: TYRA) Tyra Biosciences stock price per share is $13.18 today (as of Feb 3, 2023).

What is Tyra Biosciences's Market Cap?

(NASDAQ: TYRA) Tyra Biosciences's market cap is $556.16M, as of Feb 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Tyra Biosciences's market cap is calculated by multiplying TYRA's current stock price of $13.18 by TYRA's total outstanding shares of 42,197,431.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.